Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Pharmaceuticals
Novartis' Sandoz generic drug arm and Momenta Pharmaceuticals have formed a pact to develop follow-on versions of four existing biotechnology products. Sandoz has taken a $75 million stake in Momenta and will make milestone payments to the biotech firm of up to $188 million if all four drugs are commercialized. The collaboration expands into Europe the companies' U.S. partnership for M-Enoxaparin, a generic version of Sanofi-Aventis' Lovenox, a low-molecular-weight heparin for deep-vein thrombosis.
This article has been sent to the following recipient: